Dope Entrepreneurs
  • Research
  • News
  • Articles
  • Reviews
No Result
View All Result
  • Research
  • News
  • Articles
  • Reviews
No Result
View All Result
Dope Entrepreneurs
No Result
View All Result
Home News

Celiac Disease Patients: Drug Trials Underway

Drug could soon be available to help celiac disease patients.

hplictawa@gmail.com' by Editorial Team
May 9, 2022
in News
0
Celiac Disease Patients: Drug Trials Underway
2.8k
SHARES
6.3k
VIEWS
Share on FacebookShare on TwitterShare On Whatsapp

Medically reviewed by Onikepe Adegbola, MD, PhD

Drug in trial for celiac disease

​​​​9 Meters Biopharma confirmed that it had collaborated with Celiac.com. Celiac.com works to support the clinical trial enrollment of the company’s drug larazotide. It mainly focuses to treat gluten sensitivity disease. 

ADVERTISEMENT

At present, the drug is undergoing late-stage trials to test its safety and efficacy. All adult patients who have a six-month history of celiac disease are tested at this stage. 

9 Meters Biopharma is a clinical-stage company developing novel treatments for people with rare digestive diseases.  The website Celiac.com offers news, information, and support to those who must follow a gluten-free diet because of celiac disease. This collaboration aims to further support the enrollment in the 9 Meters’ Phase 3 study, known as CeDLara, for the celiac disease drug larazotide.

The Need for New Drug

Celiac is an autoimmune disease involving the digestive system. Inflammatory response to dietary gluten can result in disease, resulting in severe and often life-altering abdominal pain. Celiac disease patients’ only therapeutic option is to adhere to a gluten-free diet. However, it is insufficient for asymptomatic living. No matter how hard one can try avoiding gluten, there is always an unintentional consumption of trace amounts of gluten.

Therefore, this Phase 3 therapy in development can be the most effective solution against celiac disease. The company is ready to launch a new drug, larazotide, which is a gut-restricted tight-junction regulator. 

Why Is Celiac Disease Difficult To Treat?

Gluten triggers autoimmune disorders like celiac disease. Since it is a gluten-sensitive disorder, patients can only opt for a gluten-free diet. But this diet comes with several challenges. 

Wheat, barley, rye, and other grains contain gluten. Hence following the diet is quite a daunting task.

Gluten intolerance or gluten sensitivity is not the same thing as celiac disease. Some people with gluten intolerance might show similar symptoms as Celiac disease. But they do not exhibit any immune response that damages the small intestine. Hence, there is no specific drug for Celiac disease so far.

Celiac disease occurs when the body overreacts to gluten and damages the small finger-like projections along the small intestinal wall. Small intestines can’t absorb nutrients from food if their villi are injured. This can eventually result in malnutrition, loss of bone density, miscarriage, and infertility. 

Larazotide: The New Drug

Larazotide is designed to reduce the damaging effects of gluten by preventing it from leaving the digestive tract. It will mitigate the inflammation even when a small amount of gluten is consumed. A key goal of 9 Meters is to use larazotide alongside a gluten-free diet in adults with celiac disease. It will help them restore tight junctions between intestinal cells, minimize gliadin leakage, and, therefore, minimize symptoms.

Takeaway

We are excited to partner with 9 Meters to recruit participants for the Phase 3 study of larazotide and have been closely following its development. Scott Adams, CEO of Celiac.com, expressed hope that the results of this study will soon lead to the first FDA-approved prescription treatment for celiac disease. This collaboration will result in a new treatment option for celiac patients. A large percentage of people with celiac disease can go for the new drug and live life stress-free. 

Reference:

9 meters biopharma and Celiac.com announce collaboration to support clinical trial enrollment in 9 meter’s phase 3 study for celiac disease. Celiac.com. (2022, April 20). Retrieved May 3, 2022, from https://www.celiac.com/articles.html/9-meters-biopharma-and-celiaccom-announce-collaboration-to-support-clinical-trial-enrollment-in-9-meter%E2%80%99s-phase-3-study-for-celiac-disease-r5866/

Tags: celiacclinical trialgluten-free
hplictawa@gmail.com'

Editorial Team

Related Posts

20+ Laxatives Recalled for Contamination
News

20+ Laxatives Recalled for Contamination

July 29, 2022
Medical Mystery
News

A Medical Mystery Was Solved With No Medication

May 9, 2022
Next Post
Medical Mystery

A Medical Mystery Was Solved With No Medication

Antibiotics Can Induce Symptoms Of IBS, Data Suggest

Antibiotics Can Induce Symptoms Of IBS, Data Suggest

Small Intestinal Bacterial Overgrowth (SIBO) And Its Causes

Small Intestinal Bacterial Overgrowth (SIBO) And Its Causes

Follow Us

  • 9.9k Followers

Recommended

Study Confirms a Direct Relationship of Gut Microbiota with the Brain

Study Confirms A Direct Relationship Of Gut Microbiota With The Brain

10 months ago
Brief Comparison of Effective IBS Treatments

Brief Comparison of Effective IBS Treatments

10 months ago
Gut Virome Can Treat Intestinal And Immunological Diseases

Gut Virome Can Treat Intestinal And Immunological Diseases

10 months ago
Dietary Choices Are Influenced By Gut Microbiota

Dietary Choices Are Influenced By Gut Microbiota

10 months ago

Categories

  • Articles
  • General
  • News
  • Research
  • Reviews

Topics

acid reflux antibiotics bloating capsaicin causes colonoscopy constipation Crohn's Disease deficiency diabetes diarrhea Digestive enzymes diverticulitis fatigue FODMAP gluten-free gut gut bacteria gut health gut microbiome gut microbiota health healthy diet IBD IBS IBS-C IBS diet inflammation inflammatory bowel disease irritable bowel syndrome lactobacillus low FODMAP diet microbiome microbiota peppermint oil probiotic probiotics quality of life research SIBO sucrose intolerance supplement tea therapy treatment
No Result
View All Result
https://casadesante.com https://casadesante.com https://casadesante.com

Highlights

Science-Based Benefits Of Taking Digestive Enzymes For Efficient Digestive Healing

Association of Poor Vitamin and Mineral Intake to Irritable Bowel Syndrome Symptoms

A Systematic Review of the Linkage Between Irritable Bowel Syndrome and Macronutrients

Invitation To Colonoscopy Reduced Incidences Of Cancer But Not Death Through A Gold-Standard Trial

Symptoms, Causes, and Solutions to Vitamin B Deficiencies

A Meta-Analysis: The Diagnostic Yield Of Colonoscopy In IBS Patients For Organic Diseases

Trending

Clinical Research Suggests Adding a Probiotic to the Diet for Those Dealing With Depression
Research

Clinical Research Suggests Adding a Probiotic to the Diet for Those Dealing With Depression

by Ivy Totanes
January 10, 2023
0

A recently published scientific report from Basel, Switzerland, has demonstrated that probiotics can supplement antidepressant treatment. The...

Clinical Research Data Indicates Gut Flora May Be Improved by the Antioxidant Characteristics of Beer Polyphenols

Clinical Research Data Indicates Gut Flora May Be Improved by the Antioxidant Characteristics of Beer Polyphenols

January 10, 2023
FODMAP-Lowering Diet for IBS Patients

FODMAP-Lowering Diet for IBS Patients

December 8, 2022
Science-Based Benefits Of Taking Digestive Enzymes For Efficient Digestive Healing

Science-Based Benefits Of Taking Digestive Enzymes For Efficient Digestive Healing

October 25, 2022
Association of Poor Vitamin and Mineral Intake to Irritable Bowel Syndrome Symptoms

Association of Poor Vitamin and Mineral Intake to Irritable Bowel Syndrome Symptoms

October 18, 2022
Dope Entrepreneurs

Dope Entrepreneurs is the hub for all dope gut health related content. We are a groundbreaking news publication dedicated to gut health. We cover gut health research, entrepreneurship, startups and the latest trends in gut health. We serve a growing segment of patients, entrepreneurs and investors who want to learn more about gut health, the disruption and market potential in this field, and how they can benefit from the latest advances in gut health. Dope entrepreneurs is led by Onikepe Adegbola, MD PhD DipIBLM, physician, scientist, and gut health entrepreneur.

Categories

  • Research
  • News
  • Articles
  • Reviews
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms And Conditions


© 2022 Dope Entrepreneurs

No Result
View All Result
  • Research
  • News
  • Articles
  • Reviews

© 2022 Dope Entrepreneurs

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist